Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Breast cancer pill from AstraZeneca misses mark in pivotal trial
1+ day, 9+ hour ago (204+ words) STAT is a media company focused on finding and telling compelling stories about health, medicine, and scientific discovery. We produce daily news, investigative articles, and narrative projects in addition to multimedia features, podcasts, and opinion pieces. We tell our stories…...
Saidal, Roche sign partnership to localize breast cancer medicines production in Algeria
3+ day, 35+ min ago (66+ words) aps.dz Saidal, Roche sign partnership to localize breast cancer medicines production in Algeria ALGIERS - Saidal Group signed on Thursday, in Algiers, a partnership agreement with the Swiss company "Roche" Algeria with a view to localizing the production of breast…...
79% of prediction-market users have lost money, and many borrow to keep betting, survey finds
3+ day, 5+ hour ago (32+ words) Scripps News 79% of prediction-market users have lost money, and many borrow to keep betting, survey finds...
Xfinity Mobile, Comcast Business Mobile to Offer iPhone Duo, iPhone 18 Pro, and iPhone 18 Pro Max
3+ day, 18+ hour ago (566+ words) New or existing Xfinity Mobile Plus customers can get iPhone 18 Pro Max on us, or get up to $1,300 off their choice of any new iPhone model with an eligible trade-in Mobile Plus customers without a trade-in can get $400 off the…...
FDA approves AstraZeneca’s oral SERD for breast cancer despite negative adcomm vote
5+ day, 23+ hour ago (82+ words) Endpoints News FDA approves AstraZeneca’s oral SERD for breast cancer despite negative adcomm vote AstraZeneca clinched an FDA accelerated approval for its oral SERD in certain…...
AstraZeneca breast cancer drug wins US approval after trial cuts progression risk by 56%
6+ day, 6+ hour ago (64+ words) The US Food and Drug Administration’s accelerated approval is based on results from the Phase III SERENA-6 trial Indian Immunologicals seeks probe into NSQ Abhayrab vials, says samples differ from genuine batch Dr. Jitendra Singh calls for early industry partnership…...
AstraZeneca Secures FDA Nod for New Breast Cancer Therapy Etcamah
6+ day, 3+ hour ago (348+ words) AstraZeneca AZN announced that the FDA has approved Etcamah (camizestrant) in combination with a medicine belonging to the class of cyclin-dependent kinase (CDK) 4/6 inhibitors for the treatment of certain patients with advanced breast cancer. The approval was granted under the…...
Astra Zeneca receives US approval for Etcamah
6+ day, 9+ hour ago (121+ words) lifesciencenordic.com In the phase III SERENA-6 study, the combination reduced the risk of disease progression or death by 56 percent compared with standard treatment. Dialysis company hit with $15M bill after massive patient data breach Astra Zeneca receives US approval for…...
How will acquisitions power Shein’s next phase of growth?
6+ day, 13+ hour ago (22+ words) Inside Retail Asia This is for IR Pro Log in below or subcribe....
IN BRIEF: AstraZeneca wins US nod for Etcamah breast cancer combo | Financial News
6+ day, 16+ hour ago (238+ words) IN BRIEF: AstraZeneca wins US nod for Etcamah breast cancer combo London South East Investor Summit 2026 18 September, London. Save 15% with code LONDONSOUTHEAST. Get your tickethere - IN BRIEF: AstraZeneca wins US nod for Etcamah breast cancer combo AstraZeneca PLC - Cambridge, England-based…...